Non-motor symptoms (NMS) improvement is positively correlated with baseline NMS burden and improved quality of life in advanced Parkinson's disease patients treated with levodopa-carbidopa intestinal gel: a post-hoc analysis from the GLORIA registry

被引：0

作者：

Poewe, W. ^{[1
]}

Bergmann, L. ^{[2
]}

Antonini, A. ^{[3
]}

Chaudhuri, K. R. ^{[4
,5
]}

机构：

[1] Med Univ Innsbruck, Innsbruck, Austria

[2] AbbVie Inc, N Chicago, IL USA

[3] Univ Padua, Dept Neurosci, Padua, Italy

[4] Kings Coll London, London, England

[5] Kings Coll Hosp London, London, England

来源：

EUROPEAN JOURNAL OF NEUROLOGY | 2018年 / 25卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

EPR3072

引用

页码：518 / 519

页数：2

共 50 条

[1] Non-motor Symptoms (NMS) Improvement Is Positively Correlated with Baseline NMS Burden and Improved Quality of Life in Advanced Parkinson's Disease Patients Treated with Levodopa-carbidopa Intestinal Gel: A Post-hoc Analysis from the GLORIA Registry
Poewe, Werner
Bergmann, Lars
Antonini, Angelo
Chaudhuri, K. Ray
MOVEMENT DISORDERS, 2018, 33 : S92 - S92
[2] Non-motor Symptoms (NMS) Improvement is Positively Correlated with Baseline NMS Burden and Improved Quality of Life in Advanced Parkinson's Disease Patients Treated with Levodopa-carbidopa Intestinal Gel: A Post-hoc Analysis from the GLORIA Registry
Poewe, Werner
Bergmann, Lars
Antonini, Angelo
Chaudhuri, K. Ray
NEUROLOGY, 2018, 90
[3] Non-motor symptoms (nms) improvement is correlated with baseline nms burden and improved quality of life (QoL) in levodopa-carbidopa intestinal gel (LCIG) treated parkinson's disease patients
Chaudhuri, K. R.
Poewe, W.
Bergmann, L.
Yegin, A.
Antonini, A.
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 98 - 98
[4] Effects of age and disease duration on quality of life in levodopa-carbidopa intestinal gel-treated advanced Parkinson's disease patients: A post-hoc analysis from the GLORIA registry
Antonini, A.
Robieson, W.
Bergmann, L.
Yegin, A.
Poewe, W.
EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 476 - 476
[5] Effects of age and disease duration on quality of life outcomes in advanced Parkinson's disease patients treated with levodopa-carbidopa intestinal gel infusions: a post-hoc analysis from the GLORIA registry
Antonini, Angelo
Robieson, Weining
Bergmann, Lars
Yegin, Ashley
Poewe, Werner
NEUROLOGY, 2017, 88
[6] Burden of non-motor symptoms in Parkinson's disease patients predicts improvement in quality of life during treatment with levodopa-carbidopa intestinal gel
Chaudhuri, K. Ray
Antonini, A.
Robieson, W. Z.
Sanchez-Solino, O.
Bergmann, L.
Poewe, W.
EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 (04) : 581 - +
[7] Baseline characteristics that influence "off" time improvement in levodopa-carbidopa intestinal gel-treated advanced Parkinson's disease patients in the GLORIA registry
Poewe, W.
Bergmann, L.
Yegin, A.
Robieson, W.
Antonini, A.
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 187 - 187
[8] Levodopa-carbidopa intestinal gel in routine care of advanced Parkinson's disease patients: Final long-term non-motor, quality of life and safety results from the GLORIA registry
Chaudhuri, K. R.
Pirtosek, Z.
Pickut, B.
Poewe, W.
Valldeoriola, F.
Defebvre, L.
Jech, R.
Odin, P.
Winkler, C.
Szasz, J.
Onuk, K.
Yegin, A.
Bergmann, L.
Antonini, A.
MOVEMENT DISORDERS, 2016, 31 : S661 - S661
[9] Levodopa/carbidopa Intestinal Gel in Treatment of Non-Motor Symptoms in Advanced Parkinson's Disease
Kamel, W.
Al Hashel, J.
MOVEMENT DISORDERS, 2019, 34 : S645 - S645
[10] Levodopa/carbidopa intestinal gel in treatment of non-motor symptoms in advanced Parkinson's disease
Elsayed, W.
Al Hashel, J.
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405

← 1 2 3 4 5 →